6-HydroxydesmethylastemizoleAlternative Names: R 52165
Latest Information Update: 01 Sep 1998
Price : $50 *
At a glance
- Originator Janssen L.P.
- Class Antiallergics; Antihistamines
- Mechanism of Action Histamine receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypersensitivity
Most Recent Events
- 01 Sep 1998 No-Development-Reported for Allergy in Japan (Unknown route)
- 16 Sep 1996 New profile
- 16 Sep 1996 Preclinical development for Allergy in Japan (Unknown route)